This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Qi Liu in Targeted Immune Tolerance
Introduction
Qi Liu is an accomplished inventor based in Oakland, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of targeted therapies for immune tolerance.
Latest Patents
One of Qi Liu's notable patents is titled "Polymeric Nanoparticles That Target Liver Sinusoidal Endothelial Cells to Induce Antigen-Specific Immune Tolerance." This innovative approach aims to enhance the effectiveness of immunotherapies by specifically targeting liver cells, which play a crucial role in immune regulation. Qi Liu holds 1 patent related to this groundbreaking work.
Career Highlights
Qi Liu is affiliated with the University of California, where he conducts research that bridges the gap between engineering and medicine. His work focuses on creating novel solutions to complex health issues, particularly in the realm of immune response modulation.
Collaborations
Qi Liu has collaborated with esteemed colleagues such as Tian Xia and Andre E Nel. These partnerships have fostered a rich environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Qi Liu's contributions to the field of targeted immune tolerance exemplify the potential of innovative research in improving health outcomes. His work continues to inspire advancements in biomedical engineering and immunotherapy.